Navigation Links
Pollen.com Reports Five U.S. Cities with Highest Pollen Activity -- Total Prescriptions for Allergy Medications 3.7% Higher than Last Year
Date:4/13/2010

Pollen.com provides list of five areas of the U.S. with highest pollen activity

(Vocus) April 13, 2010 -- According to Pollen.com, the most visited allergy site on the Web, the five areas of the country with the highest pollen activity today are: Grand Island, NE; Lincoln, NE; Topeka, KS; Wichita, KS; Des Moines, IA.

Pollen.com provides conditions by ZIP code, updated daily, and offers 4-day forecasts. The accompanying map shows, in red, areas of the country that are experiencing the highest pollen levels.

“The allergy season is already hammering Americans with a vengeance,” said Roxanne Turner, Director of Syndicated Research at SDI, the company behind Pollen.com.

“There are several reasons why certain parts of the country are experiencing significant pollen outbreaks this year,” Turner said. “Increased groundwater levels, caused by heavy snow and rain in some areas, led to the ground retaining an enormous amount of moisture. Many parts of the country also had an exceptionally cold winter, which caused a late spring start. Many areas of the country have been experiencing unseasonably warm weather over the past few weeks, so trees that had a pent-up need to pollinate pollinated suddenly. A combination of all of these factors caused pollen levels to explode.”

“But the good news is that once all of the trees have pollinated, pollen counts will go down significantly,” Turner added.

Allergy sufferers are filling doctors’ offices, then visiting their pharmacies to fill prescriptions or buy over-the-counter therapies. SDI prescription data confirm the severity of the season. During the week ending April 2, there were 1.64 million retail prescriptions for allergy drugs. This is 3.7% higher than during the same week last year, the week ending April 3, 2009, in which there were 1.58 million prescriptions filled.

For the most recent forecast and list of the five cities with the highest pollen activity, visit Pollen.com.


About Pollen.com
Pollen.com, a division of SDI, has been supplying important information to millions of people with allergic conditions for more than 10 years. With reliable, up-to-the-minute allergy forecasts that show upcoming local airborne allergen conditions, along with the weather forecast, Pollen.com prepares allergy sufferers for the day by offering all the facts – at a glance. Among its free services, Pollen.com offers charts of current and predicted pollen levels, pollen histories, e-mail alerts, and educational materials on how to manage seasonal allergies.


About SDI
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market. SDI also serves the government and the financial services, media, and consumer packaged goods industries. Founded in 1982, SDI counts the world’s top 50 pharmaceutical and biotech firms as its clients.

###

Read the full story at http://www.prweb.com/releases/sdi/04/prweb3871624.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Pollen.com Launches Features to Customize Allergy Information - Top Allergy Web Site Provides ZIP-specific Allergy Information and Diary to Track Symptoms
2. Centage Corporation Reports 51% Growth in Revenue for Q1 over Same Period as Last Year
3. Net32, Inc., Reports Record Rate of New Product Additions
4. SDI Reports: Emergency Room Visits Covered by Medicaid Increased 6% in 2009
5. CONSORT 2010: Leading journals publish new guidelines to improve trial reports
6. Frances national program to reduce HAIs reports important successes; uses mandatory reporting
7. Public Health Reports Will Host A Meet the Author! Webcast Entitled How Healthy Could a State Be
8. Media reports may paint overly optimistic view of cancer
9. MDS Reports First Quarter Fiscal 2010 Financial Results
10. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results
11. Patheon reports first quarter fiscal 2010 results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pollen.com Reports Five U.S. Cities with Highest Pollen Activity -- Total Prescriptions for Allergy Medications 3.7% Higher than Last Year
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal safety ... the end of November. , The Chicago, Illinois, based self-defense brand has been waiting ... about the ease of taking their personal safety into their own hands. , The ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing and ... compliance with FDA rules. , The FDA has issued two draft guidances that ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and ... departments have been awarded five-year accreditation status through the Public Health Accreditation ... served by a PHAB-accredited health department now extend to more than 203 ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... right or exercise more try taking a more holistic approach and use natural ... new Amazon essential oil collection is certified USDA guaranteeing that, the new line ...
(Date:9/21/2017)... Mass. (PRWEB) , ... September 21, 2017 , ... The ... children with autism, announced today the election of Yie-Hsin Hung to the Board of ... Hung join our Board of Directors. Ms. Hung is an invaluable addition to our ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: